Matches in SemOpenAlex for { <https://semopenalex.org/work/W2743684324> ?p ?o ?g. }
- W2743684324 abstract "Developing drugs for rare disease can be challenging due to specific rare disease characteristics. The French Medical Pharmacology is structured and positioned to play a major role in orphan drug research and development due to the required expertise concentrated into pharmacology departments, exclusively implemented within the French university hospitals, public hospitals that are linked to a medical school (and often a pharmacy school) with numerous INSERM or CNRS labelled research units. In addition, these structures allow a close collaboration between researchers, academic institutions and biotech start-up (most of them being spin-off of the academic structures). Also, within university hospitals are located the clinical investigation centres, linking to the F-CRIN network and also to Inserm and hospitals, that enable care staff and researchers to be associated and clinical research protocols to be carried out on site, in full respect with ethic and regulatory aspects. As a consequence, this intra and multidisciplinary expertise offers all resource to elaborate a tailored approach for orphan drug development, in new entities as well as in repositioning. For preclinical development: drug screening, candidate selection (taking into account PK, metabolism, variability and potential toxicity) and preclinical models (iPS, animal models) that could allow a better translation to human research. For clinical development, we will mention here dose determination, safety evaluation and Orphan Drug Designation and Protocol Assistance preparation and submission. For post marketing evaluation and surveys, the pharmacovigilance, addictovigilance and pharmacoepidemiology expertise, combined with access to large databases allow a better approach to orphan drug use and safety. As outlined through two success stories (Charcot Marie Tooth, vascular Ehlers-Danlos syndrome), the added value of French Medical Pharmacology structures and expertise has been evidenced in the know-how, multidimensional and multidisciplinary approaches, allowing the development of numerous drugs that have been granted with Orphan Drug Designation and later Market Approval. Even if specific and possibly even more, the field of orphan drugs requires the respect of highest standards of safety and quality. French Medical Pharmacology intends to continue on this way and constantly improve his involvement in this field, committed to a single objective: answer the unmet medical need of patients with rare diseases." @default.
- W2743684324 created "2017-08-17" @default.
- W2743684324 creator A5016176687 @default.
- W2743684324 creator A5086914602 @default.
- W2743684324 creator A5088275687 @default.
- W2743684324 date "2017-08-24" @default.
- W2743684324 modified "2023-10-18" @default.
- W2743684324 title "Pharmacology and drug development in rare diseases: the attractiveness and expertise of the French medical pharmacology" @default.
- W2743684324 cites W132296830 @default.
- W2743684324 cites W1558594810 @default.
- W2743684324 cites W1971345346 @default.
- W2743684324 cites W1975828486 @default.
- W2743684324 cites W1977688431 @default.
- W2743684324 cites W1983965561 @default.
- W2743684324 cites W1992281996 @default.
- W2743684324 cites W1999573852 @default.
- W2743684324 cites W2012746420 @default.
- W2743684324 cites W2017408392 @default.
- W2743684324 cites W2017725542 @default.
- W2743684324 cites W2020158408 @default.
- W2743684324 cites W2030732677 @default.
- W2743684324 cites W2030840013 @default.
- W2743684324 cites W2031743034 @default.
- W2743684324 cites W2042829163 @default.
- W2743684324 cites W2043345949 @default.
- W2743684324 cites W2044439361 @default.
- W2743684324 cites W2047992983 @default.
- W2743684324 cites W2050726296 @default.
- W2743684324 cites W2055550444 @default.
- W2743684324 cites W2060175036 @default.
- W2743684324 cites W2061557450 @default.
- W2743684324 cites W2062941476 @default.
- W2743684324 cites W2064692854 @default.
- W2743684324 cites W2067089499 @default.
- W2743684324 cites W2073905521 @default.
- W2743684324 cites W2081726229 @default.
- W2743684324 cites W2097293027 @default.
- W2743684324 cites W2107799646 @default.
- W2743684324 cites W2108271440 @default.
- W2743684324 cites W2113611101 @default.
- W2743684324 cites W2119829512 @default.
- W2743684324 cites W2136428013 @default.
- W2743684324 cites W2137632714 @default.
- W2743684324 cites W2137894294 @default.
- W2743684324 cites W2141811396 @default.
- W2743684324 cites W2153707891 @default.
- W2743684324 cites W2162994122 @default.
- W2743684324 cites W2169308716 @default.
- W2743684324 cites W2169795103 @default.
- W2743684324 cites W2170474645 @default.
- W2743684324 cites W2170854435 @default.
- W2743684324 cites W2313594428 @default.
- W2743684324 cites W4302871475 @default.
- W2743684324 cites W64189273 @default.
- W2743684324 doi "https://doi.org/10.1111/fcp.12314" @default.
- W2743684324 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28779530" @default.
- W2743684324 hasPublicationYear "2017" @default.
- W2743684324 type Work @default.
- W2743684324 sameAs 2743684324 @default.
- W2743684324 citedByCount "1" @default.
- W2743684324 countsByYear W27436843242019 @default.
- W2743684324 crossrefType "journal-article" @default.
- W2743684324 hasAuthorship W2743684324A5016176687 @default.
- W2743684324 hasAuthorship W2743684324A5086914602 @default.
- W2743684324 hasAuthorship W2743684324A5088275687 @default.
- W2743684324 hasConcept C104863432 @default.
- W2743684324 hasConcept C2780035454 @default.
- W2743684324 hasConcept C509550671 @default.
- W2743684324 hasConcept C512399662 @default.
- W2743684324 hasConcept C57658597 @default.
- W2743684324 hasConcept C60644358 @default.
- W2743684324 hasConcept C63433958 @default.
- W2743684324 hasConcept C64903051 @default.
- W2743684324 hasConcept C71924100 @default.
- W2743684324 hasConcept C75480439 @default.
- W2743684324 hasConcept C86803240 @default.
- W2743684324 hasConcept C98274493 @default.
- W2743684324 hasConceptScore W2743684324C104863432 @default.
- W2743684324 hasConceptScore W2743684324C2780035454 @default.
- W2743684324 hasConceptScore W2743684324C509550671 @default.
- W2743684324 hasConceptScore W2743684324C512399662 @default.
- W2743684324 hasConceptScore W2743684324C57658597 @default.
- W2743684324 hasConceptScore W2743684324C60644358 @default.
- W2743684324 hasConceptScore W2743684324C63433958 @default.
- W2743684324 hasConceptScore W2743684324C64903051 @default.
- W2743684324 hasConceptScore W2743684324C71924100 @default.
- W2743684324 hasConceptScore W2743684324C75480439 @default.
- W2743684324 hasConceptScore W2743684324C86803240 @default.
- W2743684324 hasConceptScore W2743684324C98274493 @default.
- W2743684324 hasLocation W27436843241 @default.
- W2743684324 hasLocation W27436843242 @default.
- W2743684324 hasLocation W27436843243 @default.
- W2743684324 hasLocation W27436843244 @default.
- W2743684324 hasOpenAccess W2743684324 @default.
- W2743684324 hasPrimaryLocation W27436843241 @default.
- W2743684324 hasRelatedWork W1575700869 @default.
- W2743684324 hasRelatedWork W1603416295 @default.
- W2743684324 hasRelatedWork W188266097 @default.
- W2743684324 hasRelatedWork W1975828486 @default.
- W2743684324 hasRelatedWork W2080081537 @default.